SlideShare a Scribd company logo
1 of 4
Download to read offline
7/20/2014 WHO MEC for reproductive tract infections and disorders
http://www.uptodate.com.myaccess.library.utoronto.ca/contents/image?imageKey=OBGYN%2F60832&rank=1~150&search=contracep%C3%A7%C3%A3o&source=image_view&view=print&topicKey=OBGYN/5459&source=se… 1/4
Official reprint from UpToDate® 
www.uptodate.com ©2014 UpToDate®
World Health Organization medical eligibility for contraceptive use: Reproductive tract infections and
disorders
Condition COC CIC P/R POP
DMPA
NET­
EN
LNG/ETG
Implants
Cu­IUD LNG­IUD
Vaginal bleeding patterns
Irregular pattern without heavy bleeding 1 1 1 2 2 2 1 Initiation: 1
Continuation:
1
Heavy or prolonged bleeding (includes regular and irregular
patterns)
1 1 1 2 2 2 2 Initiation: 1
Continuation:
2
Unexplained vaginal bleeding (suspicious for serious condition)
Before evaluation 2 2 2 2 3 3 Initiation: 4 Initiation: 4
Continuation:
2
Continuation:
2
Endometriosis 1 1 1 1 1 1 2 1
Benign ovarian tumors (including cysts) 1 1 1 1 1 1 1 1
Severe dysmenorrhoea 1 1 1 1 1 1 2 1
Gestational trophoblastic disease
Decreasing or undetectable human chorionic gonadotropin
levels
1 1 1 1 1 1 3 3
7/20/2014 WHO MEC for reproductive tract infections and disorders
http://www.uptodate.com.myaccess.library.utoronto.ca/contents/image?imageKey=OBGYN%2F60832&rank=1~150&search=contracep%C3%A7%C3%A3o&source=image_view&view=print&topicKey=OBGYN/5459&source=se… 2/4
Persistently elevated human chorionic gonadotropin levels
or malignant disease
1 1 1 1 1 1 4 4
Cervical ectropion 1 1 1 1 1 1 1 1
Cervical intraepithelial neoplasia (CIN) 2 2 2 1 2 2 1 2
Cervical cancer (awaiting treatment) 2 2 2 1 2 2 Initiation: 4 Initiation: 4
Continuation:
2
Continuation:
2
Breast disease
Undiagnosed mass 2 2 2 2 2 2 1 2
Benign breast disease 1 1 1 1 1 1 1 1
Family history of cancer 1 1 1 1 1 1 1 1
Cancer
Current 4 4 4 4 4 4 1 4
Past and no evidence of current disease for five years 3 3 3 3 3 3 1 3
Endometrial cancer 1 1 1 1 1 1 Initiation: 4 Initiation: 4
Continuation:
2
Continuation:
2
Ovarian cancer 1 1 1 1 1 1 Initiation: 3 Initiation: 3
Continuation:
2
Continuation:
2
Uterine fibroids
Without distortion of the uterine cavity 1 1 1 1 1 1 1 1
With distortion of the uterine cavity 1 1 1 1 1 1 4 4
Anatomical abnormalities
That distort the uterine cavity             4 4
That do not distort the uterine cavity             2 2
Pelvic inflammatory disease (PID)
7/20/2014 WHO MEC for reproductive tract infections and disorders
http://www.uptodate.com.myaccess.library.utoronto.ca/contents/image?imageKey=OBGYN%2F60832&rank=1~150&search=contracep%C3%A7%C3%A3o&source=image_view&view=print&topicKey=OBGYN/5459&source=se… 3/4
Past PID (assuming no current risk factors of STIs)
With subsequent pregnancy 1 1 1 1 1 1 Initiation: 1 Initiation: 1
Continuation:
1
Continuation:
1
Without subsequent pregnancy 1 1 1 1 1 1 Initiation: 2 Initiation: 2
Continuation:
2
Continuation:
2
PID ­ current or within last three months 1 1 1 1 1 1 Initiation: 4 Initiation: 4
Continuation:
2
Continuation:
2
STIs (sexually transmitted infections)
Current purulent cervicitis or chlamydial infection or
gonorrhoea
1 1 1 1 1 1 Initiation: 4 Initiation: 4
Continuation:
2
Continuation:
2
Other STIs (excluding HIV and hepatitis) 1 1 1 1 1 1 Initiation: 2 Initiation: 2
Continuation:
2
Continuation:
2
Vaginitis (including trichomonas vaginalis and bacterial
vaginosis)
1 1 1 1 1 1 Initiation: 2 Initiation: 2
Continuation:
2
Continuation:
2
Increased risk of STIs 1 1 1 1 1 1 Initiation:
2/3
Initiation:
2/3
Continuation:
2
Continuation:
2
1: A condition for which there is no restriction for the use of the contraceptive method.
2: A condition where the advantages of using the method generally outweigh the theoretical or proven risks.
3: A condition where the theoretical or proven risks usually outweigh the advantages of using the method.
4: A condition which represents an unacceptable health risk if the contraceptive method is used.
COC: low­dose combined oral contraceptive; CIC: combined injectable contraceptives; P: combined patch; R: combined vaginal ring; POP: progestogen­only pill;
7/20/2014 WHO MEC for reproductive tract infections and disorders
http://www.uptodate.com.myaccess.library.utoronto.ca/contents/image?imageKey=OBGYN%2F60832&rank=1~150&search=contracep%C3%A7%C3%A3o&source=image_view&view=print&topicKey=OBGYN/5459&source=se… 4/4
DMPA: depot medroxyprogesterone acetate; NET­EN: norethisterone enantate; LNG: levonorgestrel; ETG: etonogestrel; ECP: emergency contraceptive pill;
Cu­IUD: copper intrauterine device; LNG­IUD: levonorgestrel­releasing IUDs; E­IUD: copper­IUD for emergency contraception; BARR: barrier methods; FAB:
fertility awareness­based methods; LAM: lactational amenorrhoea method; CI: coitus interruptus; STER: female and male sterilization.
Reproduced with permission from: http://www.who.int/reproductive­health/publications/mec/summary.html. Copyright © 2006 World Health Organization.
Updated and revised 2009.
Graphic 60832 Version 5.0

More Related Content

Similar to Who mec for reproductive tract infections and disorders

criminalabortion-230110180944-a1b896d6 (1).pptx
criminalabortion-230110180944-a1b896d6 (1).pptxcriminalabortion-230110180944-a1b896d6 (1).pptx
criminalabortion-230110180944-a1b896d6 (1).pptx
ssuser32a71d
 
Causes and consequence LARC WHO.pdf
Causes and consequence    LARC WHO.pdfCauses and consequence    LARC WHO.pdf
Causes and consequence LARC WHO.pdf
TayeDosane
 
IATT-Framework-May-2015
IATT-Framework-May-2015IATT-Framework-May-2015
IATT-Framework-May-2015
Jack Menke
 
Drkenmaclean 130523003241-phpapp01
Drkenmaclean 130523003241-phpapp01Drkenmaclean 130523003241-phpapp01
Drkenmaclean 130523003241-phpapp01
t7260678
 
Analyzing the Works about Causes and Factors of Infertility
Analyzing the Works about Causes and Factors of InfertilityAnalyzing the Works about Causes and Factors of Infertility
Analyzing the Works about Causes and Factors of Infertility
YogeshIJTSRD
 

Similar to Who mec for reproductive tract infections and disorders (20)

criminalabortion-230110180944-a1b896d6 (1).pptx
criminalabortion-230110180944-a1b896d6 (1).pptxcriminalabortion-230110180944-a1b896d6 (1).pptx
criminalabortion-230110180944-a1b896d6 (1).pptx
 
Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3
 
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda JainSay no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda Jain
 
Causes and consequence LARC WHO.pdf
Causes and consequence    LARC WHO.pdfCauses and consequence    LARC WHO.pdf
Causes and consequence LARC WHO.pdf
 
Management of mild covid infection in pregnancy
Management of mild covid infection in pregnancy Management of mild covid infection in pregnancy
Management of mild covid infection in pregnancy
 
Abortion seminar
Abortion seminarAbortion seminar
Abortion seminar
 
Ivf in covid 19
Ivf in covid 19Ivf in covid 19
Ivf in covid 19
 
IATT-Framework-May-2015
IATT-Framework-May-2015IATT-Framework-May-2015
IATT-Framework-May-2015
 
Drkenmaclean 130523003241-phpapp01
Drkenmaclean 130523003241-phpapp01Drkenmaclean 130523003241-phpapp01
Drkenmaclean 130523003241-phpapp01
 
Abortion (1).pdf redaemaldey hayelom presentations
Abortion (1).pdf redaemaldey hayelom presentationsAbortion (1).pdf redaemaldey hayelom presentations
Abortion (1).pdf redaemaldey hayelom presentations
 
6 Abortion.pptx
6 Abortion.pptx6 Abortion.pptx
6 Abortion.pptx
 
Do Tobacco and Alcohol Use Reduce the Risk of Ectopic Pregnancy?
Do Tobacco and Alcohol Use Reduce the Risk of Ectopic Pregnancy?Do Tobacco and Alcohol Use Reduce the Risk of Ectopic Pregnancy?
Do Tobacco and Alcohol Use Reduce the Risk of Ectopic Pregnancy?
 
Analyzing the Works about Causes and Factors of Infertility
Analyzing the Works about Causes and Factors of InfertilityAnalyzing the Works about Causes and Factors of Infertility
Analyzing the Works about Causes and Factors of Infertility
 
In Vitro Fertilisation
In Vitro FertilisationIn Vitro Fertilisation
In Vitro Fertilisation
 
Normal and abnormal delivery Dr Falakha
Normal and abnormal delivery Dr FalakhaNormal and abnormal delivery Dr Falakha
Normal and abnormal delivery Dr Falakha
 
Covid19 and fertilty final Dr.Sherbiny 19-4-2020
Covid19 and fertilty final Dr.Sherbiny 19-4-2020Covid19 and fertilty final Dr.Sherbiny 19-4-2020
Covid19 and fertilty final Dr.Sherbiny 19-4-2020
 
Abortion
AbortionAbortion
Abortion
 
Advanced ART Courses for Clinicians.pdf
Advanced ART Courses for Clinicians.pdfAdvanced ART Courses for Clinicians.pdf
Advanced ART Courses for Clinicians.pdf
 
Kuwait Newborn Screening Annual report 2015
Kuwait Newborn Screening Annual report  2015Kuwait Newborn Screening Annual report  2015
Kuwait Newborn Screening Annual report 2015
 
Emergency peripartum hysterectomy
Emergency peripartum hysterectomyEmergency peripartum hysterectomy
Emergency peripartum hysterectomy
 

More from Inaiara Bragante (20)

Aula Abordagem Comunitária
Aula Abordagem ComunitáriaAula Abordagem Comunitária
Aula Abordagem Comunitária
 
Edital prmfc2018
Edital prmfc2018Edital prmfc2018
Edital prmfc2018
 
Regimento2017
Regimento2017Regimento2017
Regimento2017
 
Rmnf2222
Rmnf2222Rmnf2222
Rmnf2222
 
Cmaj.140703.full
Cmaj.140703.fullCmaj.140703.full
Cmaj.140703.full
 
Pós teste
Pós testePós teste
Pós teste
 
Pré teste
Pré testePré teste
Pré teste
 
Pós teste
Pós testePós teste
Pós teste
 
Comunicando más notícias
Comunicando más notíciasComunicando más notícias
Comunicando más notícias
 
Ciclo de vida individual e familiar
Ciclo de vida individual e familiarCiclo de vida individual e familiar
Ciclo de vida individual e familiar
 
Bb dm – extra
Bb dm – extraBb dm – extra
Bb dm – extra
 
Bb dm2
Bb dm2Bb dm2
Bb dm2
 
Conduta terapeutica
Conduta terapeuticaConduta terapeutica
Conduta terapeutica
 
Caso clinico alcool
Caso clinico alcoolCaso clinico alcool
Caso clinico alcool
 
M1 d2a6q1 cage_2009-03-13
M1 d2a6q1 cage_2009-03-13M1 d2a6q1 cage_2009-03-13
M1 d2a6q1 cage_2009-03-13
 
Tratamento farmacológico em dependência química helio -sandra
Tratamento farmacológico em dependência química  helio -sandraTratamento farmacológico em dependência química  helio -sandra
Tratamento farmacológico em dependência química helio -sandra
 
Rz clin residentes_brasil_2
Rz clin residentes_brasil_2Rz clin residentes_brasil_2
Rz clin residentes_brasil_2
 
Aula31 07 2014
Aula31 07 2014Aula31 07 2014
Aula31 07 2014
 
Aula31 07 2014
Aula31 07 2014Aula31 07 2014
Aula31 07 2014
 
Casos clínicos (3)
Casos clínicos (3)Casos clínicos (3)
Casos clínicos (3)
 

Who mec for reproductive tract infections and disorders

  • 1. 7/20/2014 WHO MEC for reproductive tract infections and disorders http://www.uptodate.com.myaccess.library.utoronto.ca/contents/image?imageKey=OBGYN%2F60832&rank=1~150&search=contracep%C3%A7%C3%A3o&source=image_view&view=print&topicKey=OBGYN/5459&source=se… 1/4 Official reprint from UpToDate®  www.uptodate.com ©2014 UpToDate® World Health Organization medical eligibility for contraceptive use: Reproductive tract infections and disorders Condition COC CIC P/R POP DMPA NET­ EN LNG/ETG Implants Cu­IUD LNG­IUD Vaginal bleeding patterns Irregular pattern without heavy bleeding 1 1 1 2 2 2 1 Initiation: 1 Continuation: 1 Heavy or prolonged bleeding (includes regular and irregular patterns) 1 1 1 2 2 2 2 Initiation: 1 Continuation: 2 Unexplained vaginal bleeding (suspicious for serious condition) Before evaluation 2 2 2 2 3 3 Initiation: 4 Initiation: 4 Continuation: 2 Continuation: 2 Endometriosis 1 1 1 1 1 1 2 1 Benign ovarian tumors (including cysts) 1 1 1 1 1 1 1 1 Severe dysmenorrhoea 1 1 1 1 1 1 2 1 Gestational trophoblastic disease Decreasing or undetectable human chorionic gonadotropin levels 1 1 1 1 1 1 3 3
  • 2. 7/20/2014 WHO MEC for reproductive tract infections and disorders http://www.uptodate.com.myaccess.library.utoronto.ca/contents/image?imageKey=OBGYN%2F60832&rank=1~150&search=contracep%C3%A7%C3%A3o&source=image_view&view=print&topicKey=OBGYN/5459&source=se… 2/4 Persistently elevated human chorionic gonadotropin levels or malignant disease 1 1 1 1 1 1 4 4 Cervical ectropion 1 1 1 1 1 1 1 1 Cervical intraepithelial neoplasia (CIN) 2 2 2 1 2 2 1 2 Cervical cancer (awaiting treatment) 2 2 2 1 2 2 Initiation: 4 Initiation: 4 Continuation: 2 Continuation: 2 Breast disease Undiagnosed mass 2 2 2 2 2 2 1 2 Benign breast disease 1 1 1 1 1 1 1 1 Family history of cancer 1 1 1 1 1 1 1 1 Cancer Current 4 4 4 4 4 4 1 4 Past and no evidence of current disease for five years 3 3 3 3 3 3 1 3 Endometrial cancer 1 1 1 1 1 1 Initiation: 4 Initiation: 4 Continuation: 2 Continuation: 2 Ovarian cancer 1 1 1 1 1 1 Initiation: 3 Initiation: 3 Continuation: 2 Continuation: 2 Uterine fibroids Without distortion of the uterine cavity 1 1 1 1 1 1 1 1 With distortion of the uterine cavity 1 1 1 1 1 1 4 4 Anatomical abnormalities That distort the uterine cavity             4 4 That do not distort the uterine cavity             2 2 Pelvic inflammatory disease (PID)
  • 3. 7/20/2014 WHO MEC for reproductive tract infections and disorders http://www.uptodate.com.myaccess.library.utoronto.ca/contents/image?imageKey=OBGYN%2F60832&rank=1~150&search=contracep%C3%A7%C3%A3o&source=image_view&view=print&topicKey=OBGYN/5459&source=se… 3/4 Past PID (assuming no current risk factors of STIs) With subsequent pregnancy 1 1 1 1 1 1 Initiation: 1 Initiation: 1 Continuation: 1 Continuation: 1 Without subsequent pregnancy 1 1 1 1 1 1 Initiation: 2 Initiation: 2 Continuation: 2 Continuation: 2 PID ­ current or within last three months 1 1 1 1 1 1 Initiation: 4 Initiation: 4 Continuation: 2 Continuation: 2 STIs (sexually transmitted infections) Current purulent cervicitis or chlamydial infection or gonorrhoea 1 1 1 1 1 1 Initiation: 4 Initiation: 4 Continuation: 2 Continuation: 2 Other STIs (excluding HIV and hepatitis) 1 1 1 1 1 1 Initiation: 2 Initiation: 2 Continuation: 2 Continuation: 2 Vaginitis (including trichomonas vaginalis and bacterial vaginosis) 1 1 1 1 1 1 Initiation: 2 Initiation: 2 Continuation: 2 Continuation: 2 Increased risk of STIs 1 1 1 1 1 1 Initiation: 2/3 Initiation: 2/3 Continuation: 2 Continuation: 2 1: A condition for which there is no restriction for the use of the contraceptive method. 2: A condition where the advantages of using the method generally outweigh the theoretical or proven risks. 3: A condition where the theoretical or proven risks usually outweigh the advantages of using the method. 4: A condition which represents an unacceptable health risk if the contraceptive method is used. COC: low­dose combined oral contraceptive; CIC: combined injectable contraceptives; P: combined patch; R: combined vaginal ring; POP: progestogen­only pill;
  • 4. 7/20/2014 WHO MEC for reproductive tract infections and disorders http://www.uptodate.com.myaccess.library.utoronto.ca/contents/image?imageKey=OBGYN%2F60832&rank=1~150&search=contracep%C3%A7%C3%A3o&source=image_view&view=print&topicKey=OBGYN/5459&source=se… 4/4 DMPA: depot medroxyprogesterone acetate; NET­EN: norethisterone enantate; LNG: levonorgestrel; ETG: etonogestrel; ECP: emergency contraceptive pill; Cu­IUD: copper intrauterine device; LNG­IUD: levonorgestrel­releasing IUDs; E­IUD: copper­IUD for emergency contraception; BARR: barrier methods; FAB: fertility awareness­based methods; LAM: lactational amenorrhoea method; CI: coitus interruptus; STER: female and male sterilization. Reproduced with permission from: http://www.who.int/reproductive­health/publications/mec/summary.html. Copyright © 2006 World Health Organization. Updated and revised 2009. Graphic 60832 Version 5.0